As shown in Figure 4G-I, tumor volume and weight were significantly reduced in the MDA-MB-231/CLDN6+ADM group compared to the MDA-MB-231/CLDN6+control group, whereas no significant changes were observed in the MDA-MB-231/CLDN6+CQ group. This evidence concerns the gene CLDN6 and neoplasm.